Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

PLUR vs SVRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SVRE Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 3–6 Matrix Metrics)

SVRE Overall Winner 6-Pillar Tally: PLUR 2 – 2 SVRE (2 Tie) Matrix Metrics: PLUR 6 – 3 SVRE

As of Nov 17, 2026, SaverOne 2014 Ltd. (SVRE) is the stronger overall head-to-head candidate over Pluri Inc. (PLUR) in the Tradestie Institutional Equity Comparison Engine, winning 3–6 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). PLUR carries a Unified Composite Score of 28.8/100 (SELL) at $0.94 (3.6x Forward P/E, -2454.5% operating margin), whereas SVRE carries 39.3/100 (SELL) at $0.39 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: SVRE earns the overall head-to-head edge with a stronger Unified Composite Score (39.3/100 SELL vs. PLUR 28.8/100 SELL) and 0.56β · 186% Vol risk profile, whereas PLUR leads top-line expansion (-15.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although SVRE compares more favorably head-to-head, both PLUR (28.8/100 SELL) and SVRE (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: PLUR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.9); meanwhile SVRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PLUR vs SVRE
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.94
-9.19% 1D
Market Cap $15.1M
TTM Revenue $1.0M
Forward P/E 3.6x
Beta / 30D Vol 0.80β · 102% Vol
Unified Composite Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -13.4%), weak momentum, RSI 40
RSI-14: 39.9 · SMA20: $1.14 · SMA50: $1.08
SVRE NASDAQ Head-to-Head Winner
SaverOne 2014 Ltd. American Depositary Shares
Services-Computer Programming Services
$0.39
-10.27% 1D
Market Cap $1.1M
TTM Revenue $2.0M
Forward P/E N/M
Beta / 30D Vol 0.56β · 186% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -37.3%), weak momentum, RSI 28
RSI-14: 27.6 · SMA20: $0.81 · SMA50: $1.43

6-Pillar Scorecard Institutional Category Breakdown (PLUR 2 – 2 SVRE)

Columns: Metric · PLUR · SVRE
1. Valuation Multiples PLUR
Forward P/E 3.6x N/M
Trailing P/E 3.6x N/M
PEG Ratio N/M N/M
EV / Revenue 44.6x 0.6x
2. Growth & Scale PLUR
Revenue Growth (YoY) -15.8% -63.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $1.0M $2.0M
Market Cap $15.1M $1.1M
3. Profitability & Quality SVRE
Gross Margin 44.6% -41.1%
Operating Margin -2454.5% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -1022.0% -151.1%
4. Balance Sheet & Cash Flow SVRE
Cash Generation (TTM) -$22M -$34M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $30M Net Debt $0.00 Book/Sh · -151.1% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PLUR (6) vs SVRE (3)
Institutional Metric PLUR SVRE Criterion Row Edge
Market Capitalization
Scale
$15.1M $1.1M Larger Scale PLUR
Trailing P/E Ratio
Valuation
3.6x N/M Lower Multiple PLUR
Forward P/E Ratio
Valuation
3.6x N/M Lower Multiple PLUR
Revenue Growth (YoY)
Growth
-15.8% -63.0% Higher Growth PLUR
Operating Margin (TTM)
Profitability
-2454.5% 0.0% Higher Margin SVRE
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-1022.0% -151.1% Higher ROE SVRE
52-Week Range Position
Momentum
2% ($1–$5) 0% ($0–$6) Stronger Trend PLUR
Beta / 30D Volatility
Risk Regime
0.80β · 102% Vol 0.56β · 186% Vol Lower Realized Risk PLUR
Unified Institutional Score
Composite Signal
28.8 / 100 (SELL) 39.3 / 100 (SELL) Higher Composite SVRE
Trailing 12M Revenue (USD)
Operating Scale
$1.0M $2.0M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.6% -41.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 44.6x EV/Rev N/M PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$22M ($30M Net Debt) -$34M EBITDA ($0.00 Book/Sh · -151.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PLUR +89.46 pp
PLUR: +11.09% · SVRE: -78.37%
3M Horizon PLUR +40.07 pp
PLUR: -46.34% · SVRE: -86.41%
6M Horizon PLUR +27.97 pp
PLUR: -62.52% · SVRE: -90.49%
1Y Horizon SVRE +15.0 pp
PLUR: -75.53% · SVRE: -60.53%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PLUR vs SVRE. Trailing 12-month operating profitability (PLUR -2454.5% vs SVRE 0.0%) and valuation multiples (PLUR 3.6x vs SVRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PLUR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.0M
Gross Margin44.6%
Op. Margin-2454.5%
ROE / Fwd P/E-1022.0% · 3.6x
SVRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.0M
Gross Margin-41.1%
Op. Margin0.0%
ROE / Fwd P/E-151.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PLUR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PLUR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SVRE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SVRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PLUR Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $15.1M market capitalization and -2454.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SVRE Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $1.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PLUR vs SVRE Key Questions & Quantitative Answers

As of Nov 17, 2026, SaverOne 2014 Ltd. (SVRE) is the stronger overall head-to-head candidate over Pluri Inc. (PLUR) in the Tradestie Institutional Equity Comparison Engine, winning 3–6 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow). PLUR carries a Unified Composite Score of 28.8/100 (SELL) at $0.94 (3.6x Forward P/E, -2454.5% operating margin), whereas SVRE carries 39.3/100 (SELL) at $0.39 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: SVRE earns the overall head-to-head edge with a stronger Unified Composite Score (39.3/100 SELL vs. PLUR 28.8/100 SELL) and 0.56β · 186% Vol risk profile, whereas PLUR leads top-line expansion (-15.8% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although SVRE compares more favorably head-to-head, both PLUR (28.8/100 SELL) and SVRE (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PLUR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.9); meanwhile SVRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PLUR leads the Growth & Scale pillar: PLUR posts -15.8% YoY revenue growth and +0.0% YoY earnings growth on $1.0M TTM revenue (44.6% gross margin, -2454.5% operating margin), compared with SVRE at -63.0% YoY revenue growth and +0.0% YoY earnings growth on $2.0M TTM revenue (-41.1% gross margin, 0.0% operating margin). On trailing 12-month operating scale, PLUR generates $1.0M in USD-normalized revenue versus $2.0M for SVRE. In operating R&D and SG&A reinvestment, PLUR deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SVRE.

PLUR screens cheaper on headline valuation multiples. PLUR trades at 3.6x Forward P/E, 3.6x Trailing P/E, N/M PEG, and 44.6x EV/Revenue (unreported FCF margin), whereas SVRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PLUR (-1022.0% ROE) versus SVRE (-151.1% ROE) capital efficiency.

In options market volatility and institutional positioning, PLUR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.80β · 102% Vol realized risk). By comparison, SVRE carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.56β · 186% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.